CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition.
On April 2, 2018, Cord Blood America, Inc. (the “Company”) issued the Press Release attached as Exhibit 99.1 to this Current Report. The Press Release provides details related to the Company’s financial results and earnings for the fiscal year ended December 31, 2017 and the three month period ended December 31, 2017. The information included in Exhibit 99.1 is considered to be “furnished” under the Securities Exchange Act of 1934.
Item 9.01Financial Statements and Exhibits.
(d) Exhibits
The following Exhibits are furnished herewith:
|
Press Release dated April 2, 2018 |
Cord Blood America, Inc. ExhibitEX-99.1 2 cbai_ex991.htm PRESS RELEASE DATED APRIL 2,…To view the full exhibit click here
About CORD BLOOD AMERICA, INC. (OTCMKTS:CBAI)
Cord Blood America, Inc. (CBAI), through its CorCell program and its subsidiary CorCell Companies, Inc., provides cord blood and cord tissue stem cell services. CBAI’s subsidiaries include Cord Partners, Inc., CorCell Companies, Inc., CorCell, Ltd., (Cord Partners, Inc., CorCell Companies, Inc. and CorCell, Ltd. are referred to collectively as Cord), CBA Properties, Inc. (Properties), and Career Channel, Inc. CBAI and its subsidiaries engage in the various business activities, such as CBAI and Cord specialize in providing private cord blood and cord tissue stem cell storage services to families throughout the United States and Puerto Rico, and Properties was formed to hold corporate trademarks and other intellectual property. Cord’s operations provide umbilical cord blood banking and cord tissue services to expectant parents. Cord provides various services, which includes collection materials, physician and customer support, transportation, testing and cord blood storage.
